Cargando…
Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study
BACKGROUND: Several RCT studies including ours, seem to prove the role of Botulinum toxin type A (BTX-A) in the treatment of trigeminal neuralgia (TN), but no standardized dosing regimen has been established. In our study, we compare two different methods of administration: single-dose or repeated-d...
Autores principales: | Zhang, Haifeng, Lian, Yajun, Xie, Nanchang, Chen, Chen, Zheng, Yake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552618/ https://www.ncbi.nlm.nih.gov/pubmed/28799056 http://dx.doi.org/10.1186/s10194-017-0793-3 |
Ejemplares similares
-
Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia
por: Wu, Chuanjie, et al.
Publicado: (2016) -
Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: A follow-up retrospective study of 152 patients
por: Zhang, Haifeng, et al.
Publicado: (2019) -
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
por: Zhang, Haifeng, et al.
Publicado: (2014) -
Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect
por: Wu, Shouyi, et al.
Publicado: (2019) -
Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia
por: Kayani, Abdul Mueez Alam, et al.
Publicado: (2022)